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Lipids and the Kidney
Bertram L. Kasiske, Michael P. O'Donnell, William Cowardin, and William F. Keane E pidemiological studies have shown that hypertension and hypercholesterolemia are both risk factors for the development of cardiovascular disease. 1 -5 Although most investigations have focused on the independent nature of the risks resulting from hypertension and hypercholesterolemia, the data have also indicated a possible synergism in the combined influences of these and other risk factors on vascular disease. 6 In addition, several studies have found a more frequent than expected occurrence of hypertension and hypercholesterolemia in the same individuals. 7 - 9 It is unlikely that this association is the result of hypertension causing abnormalities in lipid metabolism. On the other hand, lipid abnormalities could participate in the pathogenesis of hypertension in a number of ways. The elevated systemic vascular resistance resulting from advanced atherosclerotic vascular disease, for example, may contribute to the development of hypertension in the elderly. However, recent experimental data have also suggested that lipid abnormalities associated with hypercholesterolemia may be involved in the pathogenesis of essential hypertension through mechanisms not dependent on the presence of overt vascular disease. 10 - 13 This intriguing possibility casts a new light on what is already known about the synergistic effects of hypercholesterolemia and elevated blood pressure on atherosclerosis.
The kidney may be an important link in our understanding of the interactions between abnormalities in lipid metabolism, blood pressure, and vascular disease ( Figure 1 ). There is now abundant evidence demonstrating that the kidney is a major target organ for both hypertension and lipid-induced injury. In addition, the kidney may have an important role in the pathogenesis of essential hypertension, and it is possible that lipid-induced renal alterations could contribute to the development and maintenance of elevated blood pressure. Although it is well known that advanced renal vascular disease may cause hypertension, it is also possible that earlier, more subtle, lipid-induced alterations could influence renal resistance, sodium chloride handling, or the release of vasoactive mediators from the kidney. These early lipid-associated alterations could be important in the pathogenesis of essential hypertension. Moreover, recent evidence has suggested that the kidney may play a role in lipoprotein metabolism. Thus, sufficient renal damage caused by hypertension and abnormalities in lipid metabolism could result in additional deleterious effects on circulating lipoproteins.
A clue to the potential importance of the kidney in the complex interrelation between cholesterol, blood pressure, and vascular disease is to be found in several recent epidemiological studies. In these investigations, the presence of urinary protein excretion, even in amounts not detectable by the usual clinical methods, was found to be an important predictor of cardiovascular disease mortality. 14 -16 Moreover, in at least one study, the relation between proteinuria and vascular disease was found to be statistically independent of hypertension and hypercholesterolemia. 16 Several different mechanisms could explain the. independent association between urinary protein excretion and cardiovascular disease. Indeed, the kidney could be both a target organ for, and a cause of, increased blood pressure and lipid abnormalities. Regardless of the underlying mechanisms, the relative strength of the association between proteinuria and vascular disease indicates the potential importance of the kidney in the pathogenesis or consequences, or both, of hypercholesterolemia and hypertension.
Histological studies have also pointed to a strong relation between systemic atherosclerosis and renal damage. When two groups of otherwise normal individuals with different degrees of systemic atherosclerosis were compared (patients with renal artery stenosis were excluded), the group with more severe atherosclerosis was found to have a higher incidence of nephron obsolescence and intrarenal vascular disease. 17 Although it is possible that the glomerular sclerosis and nephron destruction were caused by the intrarenal vascular disease, it is also possible that the same factors causing systemic atherosclerosis (e.g., hypertension and hyperlipidemia) resulted in the greater degree of nephron destruction. In addition, differences in the amount of renal damage may have caused differences in the incidence and severity of systemic hypertension that, in turn, could also help explain the observed association between renal damage and systemic atherosclerosis.
Effects of Hypertension on the Kidney
It has long been appreciated that hypertension causes renal injury. Early histological investigations emphasized the deleterious effects of elevated systemic blood pressure on small intrarenal arteries and arterioles.
18 ' 19 In contrast, larger, interlobar arteries appeared to be affected by age-related, atherosclerotic vascular disease that was not solely the result of hypertension. 18 In these early investigations, it was noted that the number of histologically intact nephrons appeared to be diminished in kidneys with vascular disease. 1820 This loss of functioning nephrons to glomerulosclerosis was generally attributed to ischemia caused by vascular occlusion. 20 - 21 More recent studies have challenged the notion that glomerular obsolescence is entirely the result of occlusive intrarenal vascular changes and have suggested, as an alternative explanation, that there may be other factors common to the pathogenesis of both. 17 Recent investigations have also attempted to more precisely define the pathogenesis of hypertensioninduced renal injury. The capillaries within the renal glomerulus are unique because they have both preglomerular and postglomerular arterioles. Increases in preglomerular resistance tend to decrease intraglomerular pressure and the rate of glomerular filtration. Conversely, unopposed increases in postglomerular resistance raise glomerular capillary pressure and the filtration rate. A number of micropuncture experiments have been carried out in animal models of hypertension, and these experiments have demonstrated that the amount of nephron damage is largely dependent on the extent to which systemic arterial pressure is transmitted to glomerular capillaries. 2223 Thus, in hypertensive rats with high preglomerular vascular resistance and normal intraglomerular pressures, little glomerular injury occurred.
22
- 24 However, in hypertensive rats with lower preglomerular resistance and high glomerular capillary pressure, a large amount of glomerular sclerosis resulted.
-
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- 25 Moreover, in the rat twokidney, one clip model of hypertension, elevated systemic pressure is transmitted to the glomeruli of the undipped, but not the clipped kidney. 26 As a result, hypertensive renal injury is confined to the undipped kidney. 23 It should also be recognized that the effects of systemic blood pressure and glomerular capillary pressure can be dissociated, and the importance of intraglomerular pressure in the pathogenesis of renal injury may explain why similar pharmacological reductions in systemic blood pressure may not yield equivalent decreases in renal damage. Indeed, it has been found that treatment of hypertensive rats with converting enzyme inhibitors, which reduce both systemic and intraglomerular pressure, ameliorates the amount of renal injury. 27 However, an equivalent reduction in blood pressure using pharmacological agents that lowered systemic pressure without reducing intraglomerular pressure left a substantially greater amount of renal injury. 27 Despite the recent advances in our understanding of the pathogenesis of renal injury in experimental models of hypertension, a number of questions remain unanswered. Because micropuncture experiments cannot be carried out in humans, the importance of intraglomerular pressure in the pathogenesis of hypertensive renal injury is still a matter of speculation. Short-term studies in diabetic patients with nephropathy have suggested that converting enzyme inhibitors may reduce urine protein excretion and retard the progression of renal disease. 2829 However, carefully controlled trials comparing converting enzyme inhibitors with other antihypertensive agents have not been carried out, and the long-term effects of these agents on renal injury are unknown.
The mechanism whereby increased glomerular pressure may cause renal injury is also unknown. It is possible that increased glomerular capillary pressure may damage endothelial cells directly. Alternatively, an increased flux of plasma proteins across basement membranes subjected to elevated glomerular pressure could result in cell injury through direct or indirect mechanisms. In this regard, it is important to note that, in animal models of hypertension, renal damage was often accompanied by both proteinuria and plasma lipid abnormalities. In the two-kidney Goldblatt model, in the remnant kidney model, and in the Dahl salt-sensitive rat, the development of proteinuria is accompanied by increasing plasma lipid levels (see below).
30
- 31 It is important, therefore, to examine the possible independent, additive, or synergistic effects of abnormal lipid metabolism on the renal injury associated with hypertension and proteinuria.
Effects of Hypercholesterolemia on the Kidney
Many patients with renal disease who have a pronounced reduction in functional renal mass recover enough function through compensatory mechanisms to survive a number of years. However, a slow, progressive deterioration in renal function that eventuates in end-stage renal failure frequently develops in these patients. 32 " 34 A number of mechanisms have been proposed to explain this chronic, progressive renal destruction. 35 - 37 Because patients with renal disease almost invariably have alterations in lipid metabolism, it is important to determine whether lipid abnormalities could participate in the pathogenesis of chronic renal injury.
Recent experimental data have suggested that lipid abnormalities may indeed influence the development and progression of renal injury. Studies carried out in several animal models of endogenous hyperlipidemia demonstrated that the pharmacological reduction of serum lipid levels was associated with a reduction in the amount of glomerular injury. Rats subjected to a surgical reduction in the number of functioning nephrons, the so-called remnant kidney model of chronic renal failure, developed proteinuria, hypercholesterolemia, systemic hypertension, and progressive renal injury. 27 -30 ' 38 When remnant kidney rats were treated with either of two structurally unrelated antilipemic agents (clofibric acid and lovastatin), serum cholesterol was reduced and the amount of renal injury diminished. 39 Moreover, micropuncture experiments demonstrated that the reduction in renal injury resulting from the antilipemic agents could not be explained by reduced glomerular pressures. 39 Similar investigations were carried out in the obese Zucker rat, which is a model of hyperlipidemia, type II diabetes, and progressive renal injury. 40 Treatment of obese Zucker rats with clofibric acid or lovastatin effectively reduced serum lipids and ameliorated the proteinuria and renal injury. 41 Thus, these investigations indicated that endogenous hyperlipidemia may be important in the development and progression of chronic, progressive renal injury.
Other animal models of endogenous hyperlipidemia have also been shown to develop progressive renal injury. 4243 An interesting exception is the Watanabe heritable hyperlipidemic rabbit. The Watanabe rabbit lacks the normal number of low density lipoprotein receptors, and as a result, develops pronounced hyperlipidemia. Renal injury was not found in this model. 44 Understanding the unique resistance of the Watanabe rabbit to progressive renal damage may ultimately help unravel the pathogenesis of lipid-induced renal injury.
In a number of experimental investigations, dietinduced hypercholesterolemia has also been shown to cause renal injury. Rats, rabbits, and guinea pigs fed diets containing cholesterol or increased amounts of saturated fat, or both, developed hypercholesterolemia. 45 - 49 The lipid abnormalities in these experiments were accompanied by proteinuria and progressive renal injury. 55 Pronounced changes in renal fatty acids, similar to the relative essential fatty acid deficiency profile associated with the development of atherosclerosis, have also been described in models of lipid-induced renal injury. 55 These fatty acid changes could lead to alterations in the renal production of vasoactive and inflammatory mediators that could be important in the pathogenesis of injury. Finally, investigations have also shown that renal lipid deposition is accompanied by the infiltration of the kidney with monocytes and macrophages. 45 - 56 Research into the pathogenesis of atherosclerosis has demonstrated the pivotal role that macrophages play in this process, and similar mechanisms could be important in lipidinduced renal injury.
There are also clinical data pointing to an association between abnormalities in lipid metabolism and renal injury. Indeed, renal lipid deposition has long been known to accompany glomerular injury in a number of different kidney diseases. 57 -60 Glomerular and interstitial foam cells have also been found in patients with renal disease. 61 - 62 Moreover, the spontaneous development of renal disease has been reported in patients with uncommon forms of dyslipoproteinemias.
62
- 65 On the other hand, the prevalence of renal abnormalities in patients with the more common types of hyperlipidemias, although unknown, is probably not very high. Overt renal disease does not develop in most patients with hypercholesterolemia, which suggests that other predisposing factors (e.g., immune-mediated glomerular injury or glomerular hypertension) may have to be present for significant renal damage to occur.
Possible Interactive Effects of Lipid Abnormalities and Glomerular Hypertension on Renal Injury
The experimental evidence suggests that both increased intraglomerular pressures and hyperlipidemia may independently cause renal injury. However, these two risk factors are often seen together. Thus, it is important to determine how abnormalities in lipid metabolism could interact with alterations in glomerular pressures to cause renal injury. Although experiments have shown that lipid abnormalities can cause renal injury in the absence of alterations in intraglomerular pressure, it is also possible that pronounced changes in serum lipids can cause increased glomerular pressure. To investigate this possibility, micropuncture experiments were carried out in Sprague-Dawley rats fed a high cholesterol diet. Rats were studied at a time when there was proteinuria and mild expansion of the glomerular mesangium but before there was evidence of glomerular sclerosis. Preliminary results have shown a pronounced increase in serum cholesterol levels after 4 weeks of diet. 66 Glomerular filtration and plasma flow rates were not significantly affected by the diet. However, glomerular capillary pressure was increased by 10-20% in rats fed the high cholesterol diet compared with control rats fed standard chow. 66 Thus, although lipid abnormalities may cause renal injury without elevating glomerular pressure, pronounced hypercholesterolemia may cause glomerular hypertension that could exaggerate the amount of injury.
The reason for the increase in glomerular capillary pressure associated with hypercholesterolemia is unclear. The glomerular hemodynamic changes could have been the result of the altered plasma viscosity or decreased red blood cell deformability that is known to occur in hyperlipidemia. 67 - 68 It is interesting, however, that whole kidney vascular resistance after cholesterol feeding was found to be increased in isolated kidneys perfused without red blood cells or plasma lipoproteins. 69 This latter observation suggested the possibility that factors in addition to altered blood rheology could have played a role in the glomerular hemodynamic changes. In this regard, it is possible that the increased number of mesangial cells or glomerular macrophages that are associated with cholesterol feeding could release vasoactive mediators and contribute to increased glomerular capillary pressures.
Additional experiments have been carried out to determine the extent to which alterations in glomerular pressure and serum lipids could act additively, or synergistically, to accelerate renal injury. The twokidney Goldblatt model of systemic hypertension offers a unique opportunity to examine the possible interactive effects of alterations in intraglomerular pressure and lipid abnormalities on renal injury. By placing a single clip on the left renal artery of normal rats, a pronounced elevation in systemic blood pressure occurs. Compensatory vasodilation exposes the glomeruli in the undipped kidney to pressures that are much higher than normal. 26 In contrast, intraglomerular pressure in the clipped kidney is actually lower than normal. 26 By comparing the renal histology in clipped and undipped kidneys from the same rats, the glomerular hemodynamic modulation of cholesterol-induced renal injury can be examined.
Normal, 6-week-old male Sprague-Dawley rats were fed standard chow (n=16) or standard chow supplemented with 4% cholesterol and 2% sodium cholate («=13). After 4 weeks of diet (i.e., at 10 weeks of age) a single clip was placed on the right renal artery of all rats. Systolic blood pressures were elevated in both diet groups and serum cholesterol levels were markedly increased in the cholesterol-fed rats (Table 1 ). In contrast, serum triglycerides were not significantly different between the two groups ( Table 1) . Compared with normal Sprague-Dawley rats (data not shown), albumin excretion was increased in both diet groups (Table 1) . Moreover, the cholesterol-fed rats had a significantly higher urine albumin excretion rate ( Table 1) .
The glomerular areas of undipped kidneys, determined by planar morphometry, were greater in There was no glomerulosclerosis in clipped kidneys from rats fed standard chow. However, in the clipped kidneys from rats fed high cholesterol, 0.4±0.5% had glomerulosclerosis (p<0.05 compared with those of standard chow rats). In the undipped kidneys, where glomerular pressures have been reported to be elevated, 26 the percent of glomeruli with sclerosis was 19±19% in the standard chow group versus 32±20% in the cholesterol-fed group (/?<0.05).
It is interesting that the amount of glomerular injury in the clipped kidneys of rats fed a high cholesterol diet was less than that previously observed in normotensive Sprague-Dawley rats fed the same high cholesterol diet for the same length of time (Figure 2) . Although glomerular hemodynamic measurements were not carried out in these experiments, others demonstrated that glomerular pressures were actually reduced in the clipped kidneys in the rat, two-kidney Goldblatt model. 26 Thus, these data suggest that a reduction in normal glomerular pressures may have resulted in a decrease in the amount of cholesterol-induced glomerular injury. Of course, other changes in the clipped kidneys could have also caused the observed differences in injury. It is also significant that the amount of glomerular injury in the undipped kidneys was increased compared with clipped and normal kidneys in both standard chow and cholesterol-fed rats (Figure 2) . Moreover, the injurious effects of combining the glomerular hemodynamic changes (i.e., increased pressure) in the undipped Goldblatt hypertensive rat kidney with diet-induced hypercholesterolemia appeared to be additive but not synergistic in this model (Figure 2 ).
It is also interesting that the amount of injury was proportional to the size of remaining intact glomeruli, and that cholesterol was associated with an increase in glomerular size in both clipped and undipped kidneys. The effects of the clip and of the cholesterol diet could reflect differences in glomerular hemodynamic function (i.e., increased pressure) or could reflect differences in the compensatory hypertrophic response to the different amounts of glomerular injury in the experimental groups. The latter could be particularly important, as it has recently been suggested that the renal hypertrophic response per se may be important in the pathogenesis of renal injury.
-
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A similar investigation has been carried out by others using a diet that produced a much milder degree of hypercholesterolemia. 49 Indeed, normal rats fed a high cholesterol, high fat diet had serum total cholesterol levels that were not significantly different from rats fed a control, high carbohydrate diet. 49 In that investigation, as in the present study, the greatest amount of damage was seen in undipped kidneys of rats fed the high cholesterol, high fat diet. 49 Altogether these data suggest that the relatively mild cholesterol-induced injury seen in normal kidneys may become severe when combined with other injurious factors such as increased glomerular pressure.
Possible Impact of Renal Abnormalities on Hypertension and Hypercholesterolemia
Experimental and clinical evidence suggest that hypercholesterolemia and associated lipid abnormalities may be important in the pathogenesis of essential hypertension. It has been postulated that alterations associated with hypercholesterolemia could increase smooth muscle cell contractility by altering endothelial-dependent relaxing factors, changing membrane cation transport, or affecting vascular eicosanoid production.
10 -13 ' 72 - 73 Alterations in smooth muscle contractility could, in turn, affect peripheral vascular resistance and systemic arterial pressure. Because the kidney has a unique role in the regulation of systemic blood pressure, it is also possible that cholesterol-induced alterations in renal function could be important in the pathogenesis of essential hypertension.
It is known that severe renal vascular disease caused by hypertension and hypercholesterolemia can contribute to elevated systemic blood pressure. However, the results of studies carried out using isolated kidneys from rats fed a high cholesterol diet for only 4 weeks, indicated that cholesterol may induce changes in renal vascular resistance at a time when the only histological change apparent is a mild glomerular mesangial expansion. 69 Renal vascular resistance was significantly elevated in the isolated, perfused kidneys from rats fed the high cholesterol diet, and the filtration fraction was reduced. 69 These hemodynamic changes were similar to those reported in individuals with essential hypertension. 74 -76 Because the kidneys in these experiments were isolated from lipoproteins and other possible systemic influences of the diet, the cholesterol was the apparent cause of intrinsic renal alterations that resulted in the increased resistance. Histologically, only a small amount of mesangial matrix expansion and increased mesangial cellularity were seen after 4 weeks of cholesterol feeding (personal observations). There was no glomerulosclerosis evident at this time, and no vascular abnormalities were seen (personal observations). The mechanism for these early alterations in renal resistance with cholesterol feeding is unknown. However, other investigations have shown that cholesterol feeding may directly, or indirectly, alter smooth muscle cell contractility.
11
' 73 These data suggested that hypercholesterolemia may cause early alterations in renal vascular resistance that could participate in the pathogenesis of essential hypertension.
Although patients with untreated essential hypertension are more likely to have hypercholesterolemia, 7 -9 certainly not all hypercholesterolemic patients have elevated blood pressure. Likewise, changes in serum cholesterol in experimental models of hyperlipidemia have not been uniformly associated with alterations in systemic blood pressure. 39 - 41 These data raise the possibility that hypercholesterolemia may not cause increased blood pressure per se but may be a marker for other associated abnormalities in lipoprotein or fatty acid metabolism. Alternatively, lipoprotein abnormalities associated with hypercholesterolemia may combine with other factors to cause increased blood pressure.
It is also possible that renal alterations resulting from hypercholesterolemia and hypertension could contribute to elevated plasma lipoprotein levels. Although the mechanisms are still uncertain, it is well known that patients with large amounts of urinary protein excretion have pronounced hyperlipidemia. Whether low levels of urinary protein excretion also contribute to plasma lipid abnormalities is unknown. To the extent that urinary protein excretion may reflect abnormal renal lipoprotein metabolism, it is possible that even low levels of proteinuria could contribute to abnormalities in plasma lipids. Moreover, it has also been shown that declines in glomerular filtration rate are associated with abnormalities in lipid metabolism. Indeed, individuals with glomerular filtration rates less than 50-60 ml/min begin to manifest abnormalities in circulating lipoproteins. 7778 The effect of this renal functional reduction on lipid metabolism suggests that the normal, age-related decline in glomerular filtration rate could play a role in the propensity for cholesterol levels to increase with age. 79 In summary, a substantial body of evidence points to the potentially important role of the kidney in the complex relation between hypercholesterolemia, hypertension, and mortality from vascular disease. It is generally accepted that the kidney is a major target organ for the deleterious effects of hypertension. However, recent data suggest that lipid abnormalities associated with hypercholesterolemia may also cause renal damage. In addition, alterations in renal function resulting from hypercholesterolemia or hypertension may contribute to the maintenance of elevated blood pressure and abnormal lipid metabolism. Taken all together, these data suggest that the treatment of both hypercholesterolemia and hypertension may best preserve renal function. Moreover, cholesterol and blood pressure reduction strategies that best preserve renal function may be the most effective in reducing the incidence of cardiovascular disease.
